SCHEMBL9564640

SCHEMBL9564640

O=C(Nc1ccc(F)c(Cl)c1)NS(=O)(=O)c1ccc2c(c1)CC=C2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.52
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
SLC2A1 P11166 1/20 0.47
ALDH1A1 P00352 1/20 0.46
IDH2 P48735 2/20 0.45
FBP1 P09467 1/20 0.45
LMNA P02545 2/20 0.44
HTT P42858 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KCNA1 Q09470 1/20 0.44
KCNAB1 Q14722 1/20 0.44
MAPT P10636 1/20 0.44
IDH1 O75874 2/20 0.43
IDO1 P14902 1/20 0.43
P2RY1 P47900 1/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9480079 0.92 MEN1 (0.48) CA2MEN1KMT2ASLC2A1ALDH1A1
SCHEMBL9478799 0.90 MEN1 (0.60) CA2MEN1KMT2AALDH1A1IDH2
SCHEMBL9476125 0.90 EPHX1 (0.47) CA2MEN1KMT2ASLC2A1ALDH1A1
SCHEMBL7983130 0.88 KCNA1 (0.50) CA2MEN1KMT2AALDH1A1FBP1
SCHEMBL9478434 0.87 MEN1 (0.48) CA2MEN1KMT2AALDH1A1FBP1
SCHEMBL9478350 0.87 MEN1 (0.45) CA2MEN1KMT2AALDH1A1FBP1
SCHEMBL9478180 0.87 CA2 (0.44) CA2MEN1KMT2AFBP1KCNA1
SCHEMBL9477511 0.85 TP53 (0.56) CA2MEN1KMT2AIDH2FBP1
SCHEMBL9478322 0.85 CNR2 (0.43) CA2MEN1KMT2AFBP1KCNA1
SCHEMBL9478804 0.85 MEN1 (0.48) CA2MEN1KMT2AALDH1A1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0546763-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-06-16 EP disclosed